Hem › Prostatacancer › Texas › Austin
Kliniska studier för Prostatacancer i Austin, TX
15 studier för Prostatacancer söker deltagare vid platser i och runt Austin (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
RekryterarFas 4
- Urology Austin, Austin
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Rekryterar
- Urology Austin, Austin
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
RekryterarFas 1/2
- NEXT Oncology, Austin
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekryterarFas 3
- Texas Oncology - Central/South Texas ( Site 8003), Austin
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RekryterarFas 3
- Urology Austin, Lakeway · 16 mi bort
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
RekryterarFas 3
- Research Site, Austin
- Research Site, Austin
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RekryterarFas 3
- Urology Austin, PLLC - Research Department, Austin
PSMA PET Combined With MRI for the Detection of PCa
RekryterarFas 3Friska volontärer välkomna
- Urology Austin, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RekryterarFas 1
- NEXT Oncology Austin, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
RekryterarFas 1
- NEXT Oncology, Austin, TX 78758
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekryterarObservationsstudieFriska volontärer välkomna
- Elligo Health Research, Inc., Austin
Sample Collection for Ongoing Research and Product Evaluation Study
RekryterarObservationsstudie
- Natera, Inc., Austin
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekryterarFas 1/2
- Research Site 135, Austin
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #4, Austin
Prostatacancer-studier i andra städer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andra studier i Austin
- Icke-småcellig lungcancer30 studier
- Cancer (alla typer)20 studier
- Övervikt20 studier
- Metastaserande cancer19 studier
- Kolorektal cancer19 studier
- Hjärtsvikt18 studier
- Bröstcancer18 studier
- Övervikt18 studier
- Äggstockscancer17 studier
- Endometriecancer15 studier
- Depression14 studier
- Triplenegativ bröstcancer13 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.